NCT04794348View on ClinicalTrials.gov

Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin

PHASE2UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Anticoagulant Reversal
Interventions
BIOLOGICAL

Fresh Frozen Plasma (FFP)

Autologous units of fresh frozen plasma collected from the subject by plasmapheresis

BIOLOGICAL

Freeze Dried Plasma (FDP)

Autologous units of freeze dried plasma manufactured from plasma collected from the subject by plasmapheresis

Trial Locations (1)

45219

Hoxworth Blood Center, Cincinnati

Sponsors

Collaborators (1)

Westat
All Listed Sponsors
collaborator

United States Army Medical Materiel Development Activity

FED

collaborator

Westat

OTHER

lead

Vascular Solutions LLC

INDUSTRY

NCT04794348 - Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin | Biotech Hunter | Biotech Hunter